Niagen Bioscience, Inc. (NAGE) Tops Q2 EPS by 2c

Niagen Bioscience, Inc. (NASDAQ: NAGE) reported Q2 EPS of $0.04, $0.02 better than the analyst estimate of $0.02. Revenue for the quarter came in at $31.1 million versus the consensus estimate of $28.36 million.

For earnings history and earnings-related data on Niagen Bioscience, Inc. (NAGE) click here.

You May Also Be Interested In

• UBS says bull market has further to run
• Needham Reiterates Buy Rating on Napco Security Technologies, Inc. (NSSC)
• Hershey (HSY) PT Lowered to $206; RBC Capital: 'Struggling to See a Near Term Positive Inflection'